Correction of the anaemia of chronic renal failure by recombinant human erythropoietin results in a rise in packed cell volume with a consequent increase in blood viscosity, predisposing to increased vascular resistance and the development of hypertension. Increases in blood pressure have occurred in almost half the patients treated so far with erythropoietin,' but of more serious concern is the development of seizures in seven of these patients in the United Kingdom.2 Although these bear similarities to hypertensive encephalopathy, their mechanism remains unclear.
An episode of seizures associated with erythropoietin treatment in one of our patients has been reported. We with associated breathlessness and headaches. Her weight had increased by 3 kg; 2 5 kg was removed through haemodialysis but the packed cell volume increased from 0-18 to 0-26 (figure) . Her blood pressure rose, despite oral nifedipine, to 220/110 mm Hg, when she suffered a grand mal fit. Blood pressure was subsequently controlled with intravenous hydralazine, then oral captopril. 
Comment
Neither patient had previously suffered seizures. In both fitting occurred after a sudden rise in blood pressure in association with normal fundi and computed tomograms and in the context of recent blood transfusion and increase in packed cell volume. These features closely resemble those of seizures reported in patients treated with erythropoietin while undergoing dialysis.2 As with erythropoietin, the factors precipitating fits in these patients remain unclear. In case 1 the haemoconcentration associated with haemodialvsis may have been relevant. The second patient was not fluid overloaded at the time of the first seizure but was at the time of the second, when rapid fluid removal by peritoneal dialysis might have contributed. Perhaps a rapid rise in packed cell volume resulted in both increased blood viscosity and a loss of hypoxic vasodilatationt and thus a rise in vascular resistance. These events, superimposed on a possibly abnormal cerebral vasculature, may Hay fever, hygiene, and household size
David P Strachan
Hay fever has been described as a "post industrial revolution epidemic,"' and successive morbidity surveys from British general practice suggest that its prevalence has continued to increase over the past 30 years.) Other evidence suggests a recent increase in the prevalence of asthma2 and childhood eczema.3 This paper suggests a possible explanation for these trends over time.
Subjects, methods, and results I studied the epidemiology of hay fever in a national sample of 17 414 British children born during one week in March 1958 and followed up to the age of 23 years (the National Child Development Study). Three outcomes were investigated: (a) self reported "hay fever during the past 12 months" at age 23; (b) parental report of "hay fever or allergic rhinitis in the past 12 months" at age 11; (c) parental recall of "eczema in the first year of life" elicited when the child was 7.
Cross tabulations were performed with the SAS statistical package, and multiple logistic regression models were fitted with the LR program in the BMDP statistical package.
Of the 16 perinatal, social, and environmental factors studied the most striking associations with hay fever were those for family size and position in the household in childhood. The table shows that at both 11 and 23 years of age hay fever was inversely related to the number of children in the household at age 11 (when it is assumed most families were complete). When prevalence figures were adjusted by multiple logistic regression for other significant determinants of hay fever in this cohort (see table) the associations with numbers ofolder and younger children in the household persisted. These trends in adjusted prevalence were independent of one another and each was significant (p<001, see 
